A Multi-Center Clinical Trial to Determine the Impact of a Mobile Health Application on Rheumatoid Arthritis Shared Decision Making
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Arthritis, Rheumatoid Arthritis |
| Therapuetic Areas: | Rheumatology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/15/2018 |
| Start Date: | July 20, 2018 |
| End Date: | December 31, 2020 |
A Multi-Center Cluster Randomized Controlled Clinical Trial to Determine the Impact of a Mobile Health Application on Rheumatoid Arthritis Shared Decision Making
The overall goal is to improve shared decision-making (SDM) about treatment options and
thereby enhance disease outcomes and health-related quality of life (HRQOL) for patients with
rheumatoid arthritis (RA). The objective of this study is to engage patients in using the
ArthritisPower application on a weekly basis during the time between clinic appointments for
collection of data on self-reported disease activity and patient-reported outcomes (PROs),
and to display the data using an iPad to the patients and their rheumatology health care
providers (HCPs) at the point of care for SDM.
thereby enhance disease outcomes and health-related quality of life (HRQOL) for patients with
rheumatoid arthritis (RA). The objective of this study is to engage patients in using the
ArthritisPower application on a weekly basis during the time between clinic appointments for
collection of data on self-reported disease activity and patient-reported outcomes (PROs),
and to display the data using an iPad to the patients and their rheumatology health care
providers (HCPs) at the point of care for SDM.
Inclusion criteria:
1. Age ≥ 18 years.
2. Fulfillment of the ACR/EULAR 2010 classification criteria for RA [9].
3. Moderate or high disease activity, according to CDAI ≥ 10, at the baseline visit.
4. Intent to modify DMARD therapy (i.e., adding a DMARD, switching to a new DMARD, or
changing DMARD dosage) by the patient and HCP, excluding use of oral glucocorticoids.
Exclusion criteria:
1. Current or previous use of ArthritisPower™ by the patient.
2. Lack of access to an ArthritisPower™ compatible device (e.g., smartphone, tablet, or
computer)
3. Inability or unwillingness to participate with using the ArthritisPower™ app for this
study
We found this trial at
1
site
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
